vs
Side-by-side financial comparison of Goosehead Insurance, Inc. (GSHD) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $93.1M, roughly 1.3× Goosehead Insurance, Inc.). Goosehead Insurance, Inc. runs the higher net margin — 8.6% vs 3.3%, a 5.3% gap on every dollar of revenue. On growth, Goosehead Insurance, Inc. posted the faster year-over-year revenue change (23.1% vs 4.7%). Over the past eight quarters, Goosehead Insurance, Inc.'s revenue compounded faster (9.2% CAGR vs 5.6%).
Goosehead Insurance is a U.S.-based personal lines insurance agency that offers a wide range of coverage products including auto, home, renters, flood, and specialty insurance. It partners with hundreds of insurance carriers to provide clients with tailored, cost-effective coverage options, operating via corporate locations and a national franchise network for independent agents.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
GSHD vs NATR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $93.1M | $123.8M |
| Net Profit | $8.0M | $4.1M |
| Gross Margin | — | 72.5% |
| Operating Margin | 16.1% | 4.3% |
| Net Margin | 8.6% | 3.3% |
| Revenue YoY | 23.1% | 4.7% |
| Net Profit YoY | 204.0% | 1379.4% |
| EPS (diluted) | $0.19 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $93.1M | — | ||
| Q4 25 | $105.3M | $123.8M | ||
| Q3 25 | $90.4M | $128.3M | ||
| Q2 25 | $94.0M | $114.8M | ||
| Q1 25 | $75.6M | $113.2M | ||
| Q4 24 | $93.9M | $118.2M | ||
| Q3 24 | $78.0M | $114.6M | ||
| Q2 24 | $78.1M | $110.6M |
| Q1 26 | $8.0M | — | ||
| Q4 25 | $12.4M | $4.1M | ||
| Q3 25 | $7.9M | $5.3M | ||
| Q2 25 | $5.2M | $5.3M | ||
| Q1 25 | $2.3M | $4.7M | ||
| Q4 24 | $14.9M | $-321.0K | ||
| Q3 24 | $7.6M | $4.3M | ||
| Q2 24 | $6.2M | $1.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 73.3% | ||
| Q2 25 | — | 71.7% | ||
| Q1 25 | — | 72.1% | ||
| Q4 24 | — | 72.0% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 71.4% |
| Q1 26 | 16.1% | — | ||
| Q4 25 | 29.4% | 4.3% | ||
| Q3 25 | 23.5% | 7.0% | ||
| Q2 25 | 16.7% | 3.7% | ||
| Q1 25 | 8.8% | 5.4% | ||
| Q4 24 | 29.7% | 3.8% | ||
| Q3 24 | 21.1% | 4.6% | ||
| Q2 24 | 19.7% | 5.1% |
| Q1 26 | 8.6% | — | ||
| Q4 25 | 11.8% | 3.3% | ||
| Q3 25 | 8.7% | 4.2% | ||
| Q2 25 | 5.5% | 4.6% | ||
| Q1 25 | 3.1% | 4.2% | ||
| Q4 24 | 15.8% | -0.3% | ||
| Q3 24 | 9.7% | 3.8% | ||
| Q2 24 | 7.9% | 1.2% |
| Q1 26 | $0.19 | — | ||
| Q4 25 | $0.48 | $0.23 | ||
| Q3 25 | $0.29 | $0.30 | ||
| Q2 25 | $0.18 | $0.28 | ||
| Q1 25 | $0.09 | $0.25 | ||
| Q4 24 | $0.58 | $-0.02 | ||
| Q3 24 | $0.29 | $0.23 | ||
| Q2 24 | $0.24 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.7M | $93.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-121.3M | $161.6M |
| Total Assets | $392.8M | $261.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $25.7M | — | ||
| Q4 25 | $34.4M | $93.9M | ||
| Q3 25 | $51.6M | $95.6M | ||
| Q2 25 | $92.4M | $81.3M | ||
| Q1 25 | $70.2M | $86.5M | ||
| Q4 24 | $54.3M | $84.7M | ||
| Q3 24 | $47.5M | $78.7M | ||
| Q2 24 | $23.6M | $68.7M |
| Q1 26 | — | — | ||
| Q4 25 | $289.5M | — | ||
| Q3 25 | $290.0M | — | ||
| Q2 25 | $289.8M | — | ||
| Q1 25 | $290.3M | — | ||
| Q4 24 | $82.3M | — | ||
| Q3 24 | $84.6M | — | ||
| Q2 24 | $87.0M | — |
| Q1 26 | $-121.3M | — | ||
| Q4 25 | $-95.5M | $161.6M | ||
| Q3 25 | $-105.0M | $166.7M | ||
| Q2 25 | $-78.6M | $163.7M | ||
| Q1 25 | $-88.5M | $167.1M | ||
| Q4 24 | $43.9M | $161.0M | ||
| Q3 24 | $58.3M | $162.6M | ||
| Q2 24 | $39.8M | $156.4M |
| Q1 26 | $392.8M | — | ||
| Q4 25 | $414.9M | $261.1M | ||
| Q3 25 | $403.6M | $264.8M | ||
| Q2 25 | $436.6M | $254.9M | ||
| Q1 25 | $412.6M | $252.7M | ||
| Q4 24 | $397.7M | $240.9M | ||
| Q3 24 | $358.1M | $245.3M | ||
| Q2 24 | $338.2M | $235.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.87× | — | ||
| Q3 24 | 1.45× | — | ||
| Q2 24 | 2.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $9.9M |
| Free Cash FlowOCF − Capex | — | $7.6M |
| FCF MarginFCF / Revenue | — | 6.1% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $91.8M | $9.9M | ||
| Q3 25 | $24.2M | $18.5M | ||
| Q2 25 | $28.9M | $4.3M | ||
| Q1 25 | $15.5M | $2.6M | ||
| Q4 24 | $71.5M | $12.2M | ||
| Q3 24 | $28.1M | $9.6M | ||
| Q2 24 | $18.9M | $1.3M |
| Q1 26 | — | — | ||
| Q4 25 | $86.1M | $7.6M | ||
| Q3 25 | $23.7M | $16.8M | ||
| Q2 25 | $27.2M | $3.0M | ||
| Q1 25 | $14.9M | $1.5M | ||
| Q4 24 | $70.6M | $10.0M | ||
| Q3 24 | $28.0M | $7.9M | ||
| Q2 24 | $18.6M | $-2.0M |
| Q1 26 | — | — | ||
| Q4 25 | 81.8% | 6.1% | ||
| Q3 25 | 26.2% | 13.1% | ||
| Q2 25 | 28.9% | 2.6% | ||
| Q1 25 | 19.7% | 1.3% | ||
| Q4 24 | 75.1% | 8.5% | ||
| Q3 24 | 35.9% | 6.9% | ||
| Q2 24 | 23.9% | -1.9% |
| Q1 26 | — | — | ||
| Q4 25 | 5.4% | 1.9% | ||
| Q3 25 | 0.5% | 1.3% | ||
| Q2 25 | 1.8% | 1.2% | ||
| Q1 25 | 0.8% | 1.0% | ||
| Q4 24 | 1.0% | 1.9% | ||
| Q3 24 | 0.1% | 1.5% | ||
| Q2 24 | 0.3% | 3.0% |
| Q1 26 | — | — | ||
| Q4 25 | 7.38× | 2.41× | ||
| Q3 25 | 3.06× | 3.46× | ||
| Q2 25 | 5.61× | 0.81× | ||
| Q1 25 | 6.61× | 0.55× | ||
| Q4 24 | 4.82× | — | ||
| Q3 24 | 3.72× | 2.21× | ||
| Q2 24 | 3.05× | 0.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GSHD
| Renewal Royalty Fees (2) | $43.6M | 47% |
| Renewal Commissions (1) | $18.2M | 20% |
| Contingent Commissions (1) | $10.7M | 11% |
| New Business Royalty Fees (2) | $7.9M | 8% |
| New Business Commissions (1) | $7.5M | 8% |
| Other | $3.7M | 4% |
| Initial Franchise Fees (2) | $1.6M | 2% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
